Wegener's granulomatosis in primary care by Paddock, Michael et al.
Wegener’s granulomatosis
in primary care
Michael Paddock1 ￿ Carolyn Lynch2 ￿ Lubomyr Paska2
1Poole Hospital NHS Foundation Trust, Poole, Dorset, UK
2Little Park Surgery, Hanworth, Middlesex, UK
Correspondence to: Michael Paddock. E-mail: michael.paddock@doctors.org.uk
Wegener’s granulomatosis is a potentially devas-
tating disorder that warrants prompt recognition,
referral and initiation of treatment to improve
patient prognosis.
Introduction
Wegener’s granulomatosis is an uncommon yet
potentially devastating multisystem vasculitis.
Early recognition of active disease is challenging
in the primary care setting due to the initial pres-
entation of non-speciﬁc symptoms, ultimately
resulting in a delayed diagnosis. We report the
initial presentation of acough leading to the event-
ual diagnosis of Wegener’s granulomatosis.
Case history
A 49-year-old Caucasian male warehouse worker
presented to his general practitioner (GP) with a
4-week history of a productive cough that was
worse at night and hacking in nature. He denied
any fever or night sweats. Past medical history is
relevant for focal segmental glomerulosclerosis
(FSGS), conﬁrmed by renal biopsy in 2004, and a
16-pack year history of smoking. Respiratory
examination was unremarkable. Initial impression
was of an upper respiratory tract infection and
amoxicillin was prescribed. The patient was asked
to return if the cough did not abate. One week
later, the patient returned, describing the cough as
‘mainly dry’. The patient was feeling increasingly
fatigued and unwell, denying any shortness of
breath on exertion. Respiratory examination was
again unremarkable. Pulse oximetry undertaken
in the practice revealed an oxygen saturation level
of 94% on room air: the GP prescribed erythromy-
cin for atypical cover. An urgent chest X-ray
ordered by the GP revealed multiple ill-deﬁned
opacities throughout both lung ﬁelds, the largest
of which was apparent within the left mid-zone.
In addition, there was bilateral blunting of the cost-
ophrenic angles: features suspicious of multiple
pulmonary metastases (Figure 1). The reporting
radiologist fast-tracked the patient to the respirat-
ory physicians for further assessment.
Therespiratoryphysicianssubsequentlyordered
a computed tomography (CT) scan and serum
immunological testing. CTconﬁrmed multiple pul-
monary nodules in the peripheral and basal lung
zones, demonstrating signs of early cavitation,
most suggestive of squamous cell carcinoma
withnodeﬁniteprimarylesionidentiﬁed.Immuno-
logical testing highlighted an erythrocyte sedi-
mentation rate (ESR) of 86 mm/hr, positive
perinuclear antineutrophil cytoplasmic autoanti-
bodies(p-ANCA)andasigniﬁcantlyelevatedmye-
loperoxidase (MPO) titre of 209 units. Neither
pulmonary nodule biopsy via bronchoscopy nor
CT-guided biopsies were possible, resulting in a
left-sided video-assisted thoracoscopy which
progressed to a minithoracotamy. Lung biopsy
revealed no evidence of malignant cells. However,
ﬁbrotic interstitial lung disease changes with
elements of necrosis and granulomata were
identiﬁed, indicative of Wegener’s granulomatosis.
The patient was referred to the nephrologists, to
whom the patient was already well-known given
his past history of FSGS and subsequently referred
to a physician with a special interest in Wegener’s
granulomatosis. In light of the patient’s stable
renal function, a renal biopsy was not performed
at this time. The patient has since started immuno-
suppressive therapy and is progressing well.
He is aware that further CT investigation will be
necessary over the coming months to monitor
disease progression.
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1Discussion
Wegener’s granulomatosis, an aggressive vasculi-
tic disorder with an initial presentation of
non-speciﬁc symptoms, can be difﬁcult to recog-
nize in primary care. The mean delay between
the onset of symptoms and the eventual diagnosis
ranges from 2–20 months.
1 Wegener’s granuloma-
tosis is more prevalent in men; more than 90% of
cases primarily affects Caucasian men in their
ﬁfth decade
2 at a median age of 59 years.
3
Although reported in middle age, cases have
been reported in the literature of both much
younger (13 years)
4 and older patients (71
years)
2 at initial presentation.
The pattern of symptom progression can range
from gradual to rapid life-threatening multisystem
organ failure. Although any organ system may be
affected, Wegener’s granulomatosis has a predilec-
tion for the upper airways disease (87%)
3 and
symptoms may include rhinorrhoea, sinusitis
and epistaxis,
5 in addition to pulmonary symp-
toms such as cough, pleuritis and haemoptysis.
2
The pulmonary and renal systems may be affected
to a lesser extent, 69% and 48% at presentation,
respectively.
3 Complaints of fatigue, lethargy and
weight loss indicate further systemic involvement.
Morphological evidence of renal involvement at
initial presentation, such as rapidly progressing
glomerulonephritis, can be found in up to 80%
of patients and is associated with a more severe
prognosis.
6 Established disease may also present
with a classic ‘saddle nose deformity’ which may
be particularly distressing given the aesthetic
implications. Other important causes of this
deformity include septal haematoma, congenital
syphilis and relapsing polychondritis.
5
Vasculitic disorders are strongly associated with
antineutrophil cytoplasmic autoantibodies (ANCA)
and depending upon their staining pattern can be
grouped as cytoplasmic (c-ANCA) or perinuclear
(p-ANCA). Proteinase 3 (PR3) and myeloperoxi-
dase (MPO) have been identiﬁed as the main anti-
gens for c-ANCA and p-ANCA, resulting in the
productionofanti-PR3andanti-MPO,respectively.
7
Although Wegener’s granulomatosis is classically
associated with c-ANCA in approximately 85% of
patients, it can present with a positive p-ANCA
and elevated MPO level in approximately 10% of
patients, such as in the case of our patient. ANCA
titres are reﬂective of the extent and severity of
disease and become clinically useful in distinguish-
ing between acute exacerbations of Wegener’s gran-
ulomatosis and acute infections, with the former
heralding an increase in ANCA titres.
8 Biopsy
reveals characteristic histopathological changes
consistent with Wegener’s granulomatosis: necro-
tizing granulomatous vasculitis with neutrophilic
inﬁltrates (Figure 2).
3
Immunosuppression is the hallmark of treat-
ment in active disease: Wegener’s granulomatosis
can be fatal without prompt and appropriate inter-
vention.
1 With the correct therapeutic dosing,
response to treatment is almost immediate and is
aimed at inducing remission; tapering of cyclo-
phosphamide and prednisolone therapy at a
later stage, however, may precede a relapse.
2
Side-effects of immunosuppressive therapy are
dose-dependent and may include haemorrhagic
cystitis, myelodysplastic syndrome and severe
infections.
2 Pulsed or intermittent intravenous
therapy can be utilized to limit the extent of
adverse effects, which although known to be as
effective as oral therapy,
9 is associated with an
increased incidence of relapse.
2
Figure 1
Chest radiograph report. The heart is not enlarged. There are mul-
tiple ill-deﬁned opacities throughout both lungs. The largest is
noted within the left mid-zone. There is blunting of both costo-
phrenic angles. Comment: The features are suspicious of multiple
pulmonary metastases
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Frank CrossThe use of co-trimoxazole as antibiotic prophy-
laxis has been shown to prevent the rate of relapse
through a decreased incidence of respiratory and
non-respiratory opportunistic infections.
10 Al o w
threshold for the treatment of community-acquired
infectionsshouldbeadopted.Particularcareshould
be taken when prescribing antimicrobials and non-
steroidal anti-inﬂammatory drugs, in addition to
other nephrotoxic medications, particularly in the
presence of pre-existing renal impairment. Given
that deterioration of renal function is the main
determinant of survival,
2 we recommend that a
timetable be negotiated with the patient in order
to monitor this periodically in the community.
Reported mortality of Wegener’s granulomatosis
remains considerably high at 14.6%;
3 however,
with strict adherence to treatment regimes and
regular monitoring of disease progression, ﬁve-
year survival rate is reported to be 76%.
1
Conclusion
The current guidelines for the management of
vasculitis aim to increase awareness among
primary care physicians and encourage referral
to a consultant with a special interest in vasculi-
tis.
11 In addition, close contact between both
parties is recommended for detailed advice and
continuity of patient care. The prolonged duration
of non-speciﬁc symptoms and associated disease
advancement results in a graver morbidity, mor-
tality and prognosis. Therefore, the need for an
increased awareness among primary care phys-
icians is strongly advocated. Primary care phys-
icians should be aware of presentation, treatment
protocols and provide a supportive role in
helping patients cope with the psychosocial ramiﬁ-
cations of systemic immunosuppressive therapy
and their subsequent adverse effects.
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Figure 2
Histology of lung tissue on eosin and hematoxy-
lin staining showing necrotizing vasculitis in low
power ﬁeld
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